Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Squamous Cell Carcinoma of Head and Neck 7Head and Neck Neoplasms 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Nasopharyngeal Carcinoma 4Ovarian Neoplasms 3Uterine Cervical Dysplasia 2Small Cell Lung Carcinoma 2Neoplasms 2Malnutrition 2Lung Neoplasms 2Biliary Tract Neoplasms 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Salivary Gland Neoplasms 1Recurrence 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Ototoxicity 1Oropharyngeal Neoplasms 1Neurotoxicity Syndromes 1Neoplastic Cells, Circulating 1Neoplasms, Second Primary 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Liver Neoplasms 1Kidney Diseases 1Gallbladder Neoplasms 1

Interventions

Vincristine 1Surveys and Questionnaires 1Radiotherapy 1Radiosurgery 1Methotrexate 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Genetic Association Studies 1Drug Therapy 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1Chemoradiotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Ototoxicity × Cisplatin × Clear all
NCT00683319 2013-09-20

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

National Cancer Institute (NCI)

Active not recruiting
50 enrolled
CNS

Ototoxicity, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡